110 related articles for article (PubMed ID: 28745104)
1. pH-sensitive nanoparticles for improved oral delivery of dapsone: risk assessment, design, optimization and characterization.
Chaves LL; Costa Lima SA; Vieira AC; Barreiros L; Segundo MA; Ferreira D; Sarmento B; Reis S
Nanomedicine (Lond); 2017 Aug; 12(16):1975-1990. PubMed ID: 28745104
[TBL] [Abstract][Full Text] [Related]
2. Design and statistical modeling of mannose-decorated dapsone-containing nanoparticles as a strategy of targeting intestinal M-cells.
Vieira AC; Chaves LL; Pinheiro M; Ferreira D; Sarmento B; Reis S
Int J Nanomedicine; 2016; 11():2601-17. PubMed ID: 27354792
[TBL] [Abstract][Full Text] [Related]
3. Nanosystems as modulators of intestinal dapsone and clofazimine delivery.
Chaves LL; Costa Lima SA; Vieira ACC; Barreiros L; Segundo MA; Ferreira D; Sarmento B; Reis S
Biomed Pharmacother; 2018 Jul; 103():1392-1396. PubMed ID: 29864923
[TBL] [Abstract][Full Text] [Related]
4. pH-responsive chitosan based hydrogels affect the release of dapsone: Design, set-up, and physicochemical characterization.
Chaves LL; Silveri A; Vieira ACC; Ferreira D; Cristiano MC; Paolino D; Di Marzio L; Lima SC; Reis S; Sarmento B; Celia C
Int J Biol Macromol; 2019 Jul; 133():1268-1279. PubMed ID: 31034906
[TBL] [Abstract][Full Text] [Related]
5. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
Bagre AP; Jain K; Jain NK
Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
[TBL] [Abstract][Full Text] [Related]
6. Development of PLGA nanoparticles loaded with clofazimine for oral delivery: Assessment of formulation variables and intestinal permeability.
Chaves LL; Costa Lima SA; Vieira ACC; Barreiros L; Segundo MA; Ferreira D; Sarmento B; Reis S
Eur J Pharm Sci; 2018 Jan; 112():28-37. PubMed ID: 29122712
[TBL] [Abstract][Full Text] [Related]
7. Designed Synthesis of Lipid-Coated Polyacrylic Acid/Calcium Phosphate Nanoparticles as Dual pH-Responsive Drug-Delivery Vehicles for Cancer Chemotherapy.
Wang X; Zhang M; Zhang L; Li L; Li S; Wang C; Su Z; Yuan Y; Pan W
Chemistry; 2017 May; 23(27):6586-6595. PubMed ID: 28218434
[TBL] [Abstract][Full Text] [Related]
8. Preparation of collagen peptide functionalized chitosan nanoparticles by ionic gelation method: An effective carrier system for encapsulation and release of doxorubicin for cancer drug delivery.
Anandhakumar S; Krishnamoorthy G; Ramkumar KM; Raichur AM
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):378-385. PubMed ID: 27770906
[TBL] [Abstract][Full Text] [Related]
9. PEGylated and poloxamer-modified chitosan nanoparticles incorporating a lysine-based surfactant for pH-triggered doxorubicin release.
Scheeren LE; Nogueira DR; Macedo LB; Vinardell MP; Mitjans M; Infante MR; Rolim CM
Colloids Surf B Biointerfaces; 2016 Feb; 138():117-27. PubMed ID: 26674840
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and characterization of pH-responsive nanoscale hydrogels for oral delivery of hydrophobic therapeutics.
Puranik AS; Pao LP; White VM; Peppas NA
Eur J Pharm Biopharm; 2016 Nov; 108():196-213. PubMed ID: 27634646
[TBL] [Abstract][Full Text] [Related]
11. Tacrolimus-loaded nanostructured lipid carriers for oral delivery - Optimization of production and characterization.
Khan S; Shaharyar M; Fazil M; Baboota S; Ali J
Eur J Pharm Biopharm; 2016 Nov; 108():277-288. PubMed ID: 27449630
[TBL] [Abstract][Full Text] [Related]
12. Box-Behnken optimization design and enhanced oral bioavailability of thymopentin-loaded poly (butyl cyanoacrylate) nanoparticles.
Jin X; Huang A; Ping Q; Cao F; Su Z
Pharmazie; 2011 May; 66(5):339-47. PubMed ID: 21699067
[TBL] [Abstract][Full Text] [Related]
13. Hydrophobic lapatinib encapsulated dextran-chitosan nanoparticles using a toxic solvent free method: fabrication, release property & in vitro anti-cancer activity.
Mobasseri R; Karimi M; Tian L; Naderi-Manesh H; Ramakrishna S
Mater Sci Eng C Mater Biol Appl; 2017 May; 74():413-421. PubMed ID: 28254312
[TBL] [Abstract][Full Text] [Related]
14. Multi-ion-crosslinked nanoparticles with pH-responsive characteristics for oral delivery of protein drugs.
Lin YH; Sonaje K; Lin KM; Juang JH; Mi FL; Yang HW; Sung HW
J Control Release; 2008 Dec; 132(2):141-9. PubMed ID: 18817821
[TBL] [Abstract][Full Text] [Related]
15. Thiolated Eudragit nanoparticles for oral insulin delivery: preparation, characterization and in vivo evaluation.
Zhang Y; Wu X; Meng L; Zhang Y; Ai R; Qi N; He H; Xu H; Tang X
Int J Pharm; 2012 Oct; 436(1-2):341-50. PubMed ID: 22766443
[TBL] [Abstract][Full Text] [Related]
16. A strategy for oral chemotherapy via dual pH-sensitive polyelectrolyte complex nanoparticles to achieve gastric survivability, intestinal permeability, hemodynamic stability and intracellular activity.
Deng L; Dong H; Dong A; Zhang J
Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):107-17. PubMed ID: 26515259
[TBL] [Abstract][Full Text] [Related]
17. Polyelectrolyte Complex Nanoparticles from Chitosan and Acylated Rapeseed Cruciferin Protein for Curcumin Delivery.
Wang F; Yang Y; Ju X; Udenigwe CC; He R
J Agric Food Chem; 2018 Mar; 66(11):2685-2693. PubMed ID: 29451796
[TBL] [Abstract][Full Text] [Related]
18. Multivariate Optimization of Rizatriptan Benzoate-Loaded Solid Lipid Nanoparticles for Brain Targeting and Migraine Management.
Girotra P; Singh SK
AAPS PharmSciTech; 2017 Feb; 18(2):517-528. PubMed ID: 27126007
[TBL] [Abstract][Full Text] [Related]
19. Dual chitosan/albumin-coated alginate/dextran sulfate nanoparticles for enhanced oral delivery of insulin.
Lopes M; Shrestha N; Correia A; Shahbazi MA; Sarmento B; Hirvonen J; Veiga F; Seiça R; Ribeiro A; Santos HA
J Control Release; 2016 Jun; 232():29-41. PubMed ID: 27074369
[TBL] [Abstract][Full Text] [Related]
20. Emerging Technologies to Target Drug Delivery to the Skin - the Role of Crystals and Carrier-Based Systems in the Case Study of Dapsone.
Schneider-Rauber G; Argenta DF; Caon T
Pharm Res; 2020 Nov; 37(12):240. PubMed ID: 33169237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
